Genomics Institute of the Novartis Research Foundation
Triazolopyrimidine compounds and uses thereof
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder:wherein R1, R2, R3, R4, R5, and n are as defined herein.
Novartis AG
A A A C A A A A A
A61P A61P A61K C07D A61K A61K A61K A61P A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional
Long Martin Zhengtian Ling Ji Yue (Jeff) Kehao Yuan Qiong Wei Yongfeng Ying Man Hailong Xiang-Ju Justin Ho Man
Wang Sendzik Yu Li Zhang Zhao Mi Zhang Qi Sun Huang Zhang Zhang Gu Chan